Anti-melanoma differentiation-associated gene 5 (MDA5) antibody is considered a specific serological marker in dermatomyositis (DM), which is typically linked to the amyopathic phenotype and rapidly progressive interstitial lung disease (ILD) (1). This evidence concerns the gene IFIH1 and dermatomyositis.